Methods for Treating Hypercholesterolemia
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 60/867,395, filed Nov 27, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,084,437 | Methods for Treating Hypercholesterolemia In force · High confidence UsedRemaining | Ionis Pharmaceuticals, Inc. | In force | High confidence | ||
| US 8,664,190 | Methods for Treating Hypercholesterolemia In force · Medium confidence | Ionis Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 8,912,160 | Methods for Treating Hypercholesterolemia In force · Medium confidence | Ionis Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 9,650,636 | Methods for Treating Hypercholesterolemia In force · Medium confidence | Ionis Pharmaceuticals, Inc. | In force | Medium confidence | ||
| US 10,858,657 | Methods for Treating Hypercholesterolemia In force · Low confidence | Ionis Pharmaceuticals, Inc. | In force | Low confidence | ||
| US 11,530,410 | Methods for Treating Hypercholesterolemia In force · Low confidence | Ionis Pharmaceuticals, Inc. | In force | Low confidence | ||
| Application 15/483,992 | Methods for Treating Hypercholesterolemia Abandoned Abandoned Aug 13, 2018 | Ionis Pharmaceuticals, Inc. | Abandoned | Abandoned Aug 13, 2018 | ||
| Application 17/987,064 | Methods for Treating Hypercholesterolemia Abandoned Abandoned Dec 16, 2024 | Ionis Pharmaceuticals, Inc. | Abandoned | Abandoned Dec 16, 2024 | ||
| Application 18/959,229 | Methods for Treating Hypercholesterolemia Pending Not granted | Ionis Pharmaceuticals, Inc. | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Ionis Pharmaceuticals, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.